| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/17/2003 | WO2002102340A3 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations |
| 07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |
| 07/17/2003 | WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/17/2003 | WO2002031134A3 Novel serine protease genes related to dppiv |
| 07/17/2003 | WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses |
| 07/17/2003 | US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics |
| 07/17/2003 | US20030134898 N-Acetylsulfamic acid derivatives |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease |
| 07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
| 07/17/2003 | US20030134319 Amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides |
| 07/17/2003 | US20030133991 Composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in carrier, which, when applied to open wound, modulates activity of MMP-2 and/or MMP- 9 in wound; ulcer treatment |
| 07/17/2003 | US20030133988 Immunomodulation accomplished by administration of immunomodulatory polynucleotide/microcarrier complexes comprising 3-6 mer immunomodulatory oligonucleotides |
| 07/17/2003 | US20030133969 Topical agent capable of disrupting membrane or protein conformation in a target cell, tissue or microbe; does not contain nonoxynol-9, benzalkonium chloride or menfegol |
| 07/17/2003 | US20030133961 Cosmetic compositions for reducing and method of using the same |
| 07/17/2003 | US20030133959 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 07/17/2003 | US20030133958 Maslinic acid, salts and derivatives |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133889 Treating skin and/or mucous membrane by applying an aqueous solution of ascorbic acid or a derivative stabilized by the polymer; oxidation resistance; sunscreen agents; combatting pollution, sunburn; free radical scavengers; skin tone |
| 07/17/2003 | US20030133880 Powdery pharmaceutical compositions for inhalation |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2472585A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | CA2472180A1 Hair follicle growth |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2472151A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471972A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | CA2471880A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | CA2471657A1 Methods for improving the aesthetic appearance of skin |
| 07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 07/16/2003 | EP1327444A1 Antipruritic agent |
| 07/16/2003 | EP1327434A1 Nanoemulsion comprising metabolites of ginseng saponin and a skin-care composition for anti-aging containing the same |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
| 07/16/2003 | EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1430596A New gamma selective retinoids |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1430505A Microspheres for active embolization |
| 07/16/2003 | CN1429617A Application of castor bean in preparation of medicine for disease related to sex |
| 07/16/2003 | CN1429609A Exterior-applied Chinese medicine for treating burns and scalds |
| 07/16/2003 | CN1429604A Medicine for treating psoriasis |
| 07/16/2003 | CN1429585A Face beautifying agent and its manufacturing method |
| 07/16/2003 | CN1429569A Health-care food for beautifying hair |
| 07/16/2003 | CN1429554A Compound beri-beri ointment |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114589C Method of rendering organic compounds soluble in fatty systems, complexes of such compounds and various applications of complexes |
| 07/16/2003 | CN1114442C Burns treating ointment |
| 07/16/2003 | CN1114439C Medicine for treating dermopathy and preparing process thereof |
| 07/16/2003 | CN1114398C Bath lotion and preparation process thereof |
| 07/16/2003 | CN1114397C Massage pills |
| 07/16/2003 | CN1114395C Skin-care ecological nutritive cream of forest frog's oviduct fat and its preparing process |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593370 Topical capsaicin preparation |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593353 p53 inhibitors and therapeutic use of the same |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593319 Fusidic acid derivatives |